Hideki Kunichika

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Diffusion Weighted Imaging

Metastatic Colorectal Cancer

Contrast Enhanced Ultrasound

Top Venues

Diagnostics (Basel, Switzerland)

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Ryosuke Taiji, Nagaaki Marugami, Aki Marugami, Takahiro Itoh, Sho Shimizu, Ryota Nakano, Yuki Hoda, Hideki Kunichika, Tetsuya Tachiiri, Kiyoyuki Minamiguchi, Satoshi Yamauchi, Toshihiro Tanaka
Multimodality Imaging of Primary Hepatic Lymphoma: A Case Report and a Literature Review. Diagnostics (Basel, Switzerland) 14 (3) (2024)
Tetsuya Tachiiri, Kiyoyuki Minamiguchi, Ryosuke Taiji, Takeshi Sato, Shohei Toyoda, Takeshi Matsumoto, Yuto Chanoki, Hideki Kunichika, Satoshi Yamauchi, Sho Shimizu, Hideyuki Nishiofuku, Nagaaki Marugami, Yuki Tsuji, Tadashi Namisaki, Hitoshi Yoshiji, Toshihiro Tanaka
Effects of Short-Term Lenvatinib Administration Prior to Transarterial Chemoembolization for Hepatocellular Carcinoma. Cancers 16 (9) (2024)
Hideki Kunichika, Kiyoyuki Minamiguchi, Tetsuya Tachiiri, Kozo Shimizu, Ryosuke Taiji, Aya Yamada, Ryota Nakano, Mariko Irizato, Satoshi Yamauchi, Aki Marugami, Nagaaki Marugami, Hayato Kishida, Hiroyuki Nakagawa, Megumi Takewa, Ken Kageyama, Akira Yamamoto, Eisuke Ueshima, Keitaro Sofue, Ryuichi Kita, Hiroyuki Kurakami, Toshihiro Tanaka
Prediction of Efficacy for Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma with Hepatobiliary-Phase Gadolinium Ethoxybenzyl-Diethylenetriaminepentaacetic Acid MRI. Cancers 16 (12) (2024)
Ryosuke Taiji, Nagaaki Marugami, Aki Marugami, Takahiro Itoh, Sho Shimizu, Ryota Nakano, Yuki Hoda, Hideki Kunichika, Tetsuya Tachiiri, Kiyoyuki Minamiguchi, Satoshi Yamauchi, Toshihiro Tanaka
Multimodality Imaging of Primary Hepatic Lymphoma: A Case Report and a Literature Review. Diagnostics (Basel, Switzerland) 14 (3) (2024)
Hideki Kunichika, Kiyoyuki Minamiguchi, Tetsuya Tachiiri, Kozo Shimizu, Ryosuke Taiji, Aya Yamada, Ryota Nakano, Mariko Irizato, Satoshi Yamauchi, Aki Marugami, Nagaaki Marugami, Hayato Kishida, Hiroyuki Nakagawa, Megumi Takewa, Ken Kageyama, Akira Yamamoto, Eisuke Ueshima, Keitaro Sofue, Ryuichi Kita, Hiroyuki Kurakami, Toshihiro Tanaka
Prediction of Efficacy for Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma with Hepatobiliary-Phase Gadolinium Ethoxybenzyl-Diethylenetriaminepentaacetic Acid MRI. Cancers 16 (12) (2024)
Tetsuya Tachiiri, Kiyoyuki Minamiguchi, Ryosuke Taiji, Takeshi Sato, Shohei Toyoda, Takeshi Matsumoto, Yuto Chanoki, Hideki Kunichika, Satoshi Yamauchi, Sho Shimizu, Hideyuki Nishiofuku, Nagaaki Marugami, Yuki Tsuji, Tadashi Namisaki, Hitoshi Yoshiji, Toshihiro Tanaka
Effects of Short-Term Lenvatinib Administration Prior to Transarterial Chemoembolization for Hepatocellular Carcinoma. Cancers 16 (9) (2024)
Natsuhiko Saito, Hideyuki Nishiofuku, Takeshi Sato, Shinsaku Maeda, Kiyoyuki Minamiguchi, Ryosuke Taiji, Takeshi Matsumoto, Yuto Chanoki, Tetsuya Tachiiri, Hideki Kunichika, Nagaaki Marugami, Toshihiro Tanaka
Predictive Factors of Complete Response to Transarterial Chemoembolization in Intermediate Stage Hepatocellular Carcinoma beyond Up-To-7 Criteria. Cancers 15 (9) (2023)
Tetsuya Tachiiri, Hideyuki Nishiofuku, Shinsaku Maeda, Takeshi Sato, Shohei Toyoda, Takeshi Matsumoto, Yuto Chanoki, Kiyoyuki Minamiguchi, Ryosuke Taiji, Hideki Kunichika, Satoshi Yamauchi, Takahiro Ito, Nagaaki Marugami, Toshihiro Tanaka
Vascular Normalization Caused by Short-Term Lenvatinib Could Enhance Transarterial Chemoembolization in Hepatocellular Carcinoma. Current oncology (Toronto, Ont.) 30 (5) (2023)
Natsuhiko Saito, Hideyuki Nishiofuku, Takeshi Sato, Shinsaku Maeda, Kiyoyuki Minamiguchi, Ryosuke Taiji, Takeshi Matsumoto, Yuto Chanoki, Tetsuya Tachiiri, Hideki Kunichika, Nagaaki Marugami, Toshihiro Tanaka
Predictive Factors of Complete Response to Transarterial Chemoembolization in Intermediate Stage Hepatocellular Carcinoma beyond Up-To-7 Criteria. Cancers 15 (9) (2023)